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Recent efforts, including the launching
of PLoS Neglected Tropical Diseases, have
begun to bring attention to conditions now
broadly referred to as neglected tropical
diseases (NTDs). Many of these diseases,
which affect the socioeconomically disad-
vantaged of the world, had not been
thoroughly examined and included in
large-scale burden assessment undertak-
ings, such as the Global Burden of Disease
Study, and had not been prioritized at a
regional or global level [1]. Recently,
global partnerships have been developed
that are pushing for inclusion of NTDs in
infectious disease research and disease
control initiatives. However, an important
group of disease-causing organisms has
often been excluded, namely the zoonotic
larval cestodes [2].
Echinococcosis, attributable to the lar-
val stage of Echinococcus spp., and cysticer-
cosis, caused by larval Taenia solium, are
two such parasitic conditions. They are
both widely distributed throughout the
world. Both disproportionately affect the
socioeconomically disadvantaged seg-
ments of society and cause serious human
morbidity due to the effect of the parasite
larvae in the liver, lung, or brain of the
host. Both have also caused collateral
economic damages to poor farmers be-
cause of infection of their animals, which
are no longer as marketable.
The most important zoonotic Echinococ-
cus species, from a public health stand-
point, are E. granulosus and related species
that cause cystic echinococcosis (CE), and
E. multilocularis, the cause of alveolar
echinococcosis. Humans are infected by
ingesting eggs shed in the feces of canine
definitive hosts. The result is the formation
of slow-growing larval cysts in the liver,
lungs, or other organ systems, which
eventually produce clinical signs from
mass effects, allergic reactions, or through
tissue necrosis/fibrosis [3]. In contrast,
humans act as the definitive host for Taenia
solium infection, with the adult worms
residing in the intestinal tract. Swine
become infected upon ingestion of eggs
shed in the feces of an infected human
tapeworm carrier resulting in larval cyst
formation (cysticercosis) in muscle and
other tissues. The cycle continues when
humans acquire the tapeworm form by
ingesting undercooked infected pork. Hu-
mans can also become infected with the
larval stage of this parasite via the
ingestion of infective eggs. When cyst
formation occurs in the brain, the resulting
condition is termed neurocysticercosis
(NCC), a major cause of seizures and
epilepsy in T. solium–endemic regions
[4,5].
Only recently, the World Health Orga-
nization included echinococcosis and cys-
ticercosis as part of a Neglected Zoonosis
subgroup for its 2008–2015 strategic plan
for the control of NTDs [6,7]. Both
echinococcosis and cysticercosis are also
to be included in a review of the Global
Burden of Disease Study, which is cur-
rently underway. However, even with
these steps forward, there are limited data
with which to estimate the global burden
of disease from larval cestodes. In contrast
to many of the NTDs, which can be
readily identified by obvious clinical le-
sions (e.g., filariasis, Buruli ulcer) or a
simple laboratory test (e.g., stool examina-
tion for geohelminths), diagnosis of larval
cestode infections typically requires a high
index of suspicion and access to confirma-
tory imaging studies. For example, initial
diagnosis of CE typically requires imaging
studies such as abdominal ultrasound or
chest X ray [8]. These techniques have
only recently been moved into field
studies. However, when imaging studies
have been applied in endemic areas, the
burden of disease is quite high [9,10].
While CE is not, strictly speaking, a
tropical disease, it does result in a high
disease burden in under-developed regions
of the world, including areas of North
Africa, the Middle East, Central Asia, and
China. Preliminary estimates of the global
burden of CE, in terms of disability-
adjusted life years (DALYs) lost, suggest
that CE may cause disability on at least a
similar level to numerous better-known
NTDs, including Chagas disease, dengue,
onchocerciasis, and trypanosomiasis [11].
However, even this estimate is likely
conservative since it fails to account for
the burden of unrecognized disease.
NCC, which is due to T. solium, is also
widely distributed, with endemic regions
in Mexico, Central and South America,
and parts of Africa and Asia [4]. It causes
a wide range of neurologic symptoms that
can be confused with other conditions.
Diagnosis typically requires access to
computer tomography (CT) or magnetic
resonance imaging (MRI) scans. When
these techniques have been applied in
endemic areas, NCC has been recognized
as the major cause of seizure disorders as
well as an important cause of hydroceph-
alus and stroke [12,13]. In some field
studies, it caused a substantial proportion
of all cases of epilepsy. The number of
DALYs lost globally due to T. solium has
not yet been determined, but is most likely
substantial [14–16]. In addition to human
health losses, both of these conditions also
result in considerable livestock-associated
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The question then arises as to why these
parasitic diseases, obviously important
from both a human health and a livestock
production perspective, are still not receiv-
ing the attention they are due. One
possibility is the difficulty in diagnosis.
While the advanced diagnostic techniques
required to diagnose these parasites are
becoming more prevalent throughout the
world, the populations most at risk still
have limited physical and financial access
to these imaging modalities. For example,
information is known about CE in no-
madic Turkana populations of Kenya only
because a small group of dedicated
researchers has been undertaking commu-
nity ultrasound studies in these villages for
over two decades [17]. However, CE
extends far beyond the borders of these
hyperendemic villages, with limited ability
for early diagnosis. In addition, without a
definitive image-based diagnosis, many of
the clinical manifestations of NCC, in-
cluding epilepsy, acute symptomatic sei-
zures, severe headaches, and psychiatric
disturbances, are not attributed to larval
cestode infection. As a result, both condi-
tions are vastly under-reported in the
regions where they have the largest
impact.
Another reason for the zoonotic larval
cestodes’ neglected status may be the
chronic nature of these conditions [18].
Clinical signs associated with echinococ-
cosis can take five to ten years to develop,
with clinical signs associated with NCC
also taking months or years to appear. For
government administrations dealing with a
myriad of public health crises, this lack of
acute symptoms may make these condi-
tions seem less dire than those with a
shorter incubation period. In addition,
unlike diseases with acute outbreaks that
result in national and international media
coverage, echinococcosis and NCC are
rarely, if ever, publicized. As a result, there
is a lack of outcry from the populations of
endemic regions to pressure local govern-
ments to implement additional control
efforts. Since both conditions also affect
livestock, it is possible that the perception
of the public health sector, in many
endemic regions, is that these diseases
are an agricultural problem and are,
therefore, primarily the responsibility of
the agricultural/veterinary sector. As with
human disease, livestock disease is also
slow and insidious, with many farmers not
recognizing that they have a problem.
A third potential reason for the neglect-
ed status of both echinococcosis and
cysticercosis is that treatment is difficult
[18]. Treatment for both diseases can
include surgical resection of cysts (this is
especially common for echinococcosis),
treatment with an anthelminthic agent
(which may be prolonged and is often only
partially effective), and additional support-
ive therapy, such as anti-inflammatory and
anticonvulsant medications for NCC [3,4].
Finally, control program implementation,
for both of these conditions, is a long-term
commitment, which may include anthel-
minthic treatment of definitive hosts,
vaccination, treatment and/or inspection
of intermediate hosts, and education
initiatives [19,20]. Effective control, there-
fore, requires cooperation between the
medical establishment, public health sec-
tor, and the veterinary/agricultural sector,
with communication between these fields
often not well established in many devel-
oping regions. When proposing control
measures for an NTD, a systems approach
with other co-endemic NTDs has been
suggested as a cost-effective option [7,21].
This approach may also be applicable to
the zoonotic larval cestodes. For example,
the integrated control of CE, leishmania-
sis, and rabies has been proposed for co-
endemic regions of North Africa, and a
combined approach towards echinococco-
sis, rabies, and tuberculosis control has
been suggested for regions of East Africa
and China [18]. Cysticercosis is also likely
to be a good candidate for an integrated
approach to control, such as in areas co-
endemic with schistosomiasis.
An increased focus on burden assess-
ments related to zoonotic larval cestodes
should increase the profile of these impor-
tant conditions. However, until the full
socioeconomic impact of echinococcosis
and cysticercosis is better defined, and an
improved linking of the public health and
agricultural/veterinary sectors is achieved,
we believe that zoonotic larval cestodes
will continue to be treated like neglected
stepchildren, even among the NTDs. If the
goal of recent NTD endeavors is to truly
address those conditions that significantly
impact the world’s most disadvantaged
populations, greater attention needs to be
directed at zoonotic larval cestode infec-
tions, especially given their impact on both
human health and livestock production,
their difficulty in diagnosis, their chronic
nature, and the complexity of treatment
and control.
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